查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1597853

Tapentadol市場：按應用程式、最終用戶分類 - 全球預測 2025-2030

Tapentadol Market by Application (Cough Treatment, Pain Management), End User (Clinic, Hospital, Pharmacy) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年Tapentadol市值為38.6億美元，預計到2024年將達到41億美元，預計複合年成長率為6.38%，到2030年將達到59.5億美元。

Tapentadol是一種用於疼痛治療的止痛藥物，特別是用於治療中度至重度急性疼痛，並佔據醫藥​​市場的重要部分。其雙重作用機制結合了鴉片受體激動和去甲腎上腺素再攝取抑制，可增強疼痛控制，且副作用可能比傳統鴉片類藥物更少。全球對鴉片類藥物濫用的擔憂增加了對替代性疼痛管理解決方案的需求，這使得Tapentadol多成為醫療保健提供者的一個有吸引力的選擇。Tapentadol主要用於醫院、門診和安寧療護領域。Tapentadol的最終用途範圍從急性術後疼痛管理到慢性疼痛，例如神經病變疼痛和癌症疼痛。慢性疼痛疾病盛行率上升、老年人口增加以及對高效、安全疼痛治療方案的需求不斷增加等因素正在影響市場的成長。此外，對疼痛管理療法的監管支持以及正在進行的探索Tapentadol多其他潛在用途的臨床試驗也帶來了重大機會。公司可以透過開發新型藥物輸送系統和研究聯合治療來利用這些優勢，以提高療效和患者依從性。然而，市場面臨諸如對鎮痛藥嚴格的監管要求、潛在的依賴性以及來自傳統鴉片類藥物和新型非鴉片類鎮痛藥的競爭等限制。進一步的挑戰包括關於鴉片類藥物使用和嚴格的醫藥品認證過程的持續爭論。為了克服這些障礙，重點關注創新和研究領域，例如改進配方、防濫用特性和個人化醫療方法。該市場競爭激烈，但提供了重要的成長途徑，因為利用數位健康平台和人工智慧驅動的疼痛管理解決方案等技術進步的公司可以獲得競爭優勢。了解這些動態對於努力提高市場地位並提供永續疼痛管理解決方案的公司至關重要。

主要市場統計
基準年[2023] 38.6億美元
預測年份 [2024] 41億美元
預測年份 [2030] 59.5億美元
複合年成長率（%） 6.38%

市場動態：揭示快速發展的Tapentadol市場的關鍵市場洞察

Tapentadol市場正在因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 慢性肌肉骨骼疼痛的高發生率
    • 對非處方止痛藥的需求增加
    • 糖尿病盛行率上升，鎮痛藥需求增加
  • 市場限制因素
    • Tapentadol相關的副作用
  • 市場機會
    • 治療和治療開發的進展
    • 透過線上藥局擴大供應
  • 市場問題
    • 嚴格的政府法規和替代品的可用性

波特的五力：駕馭他Tapentadol市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解Tapentadol市場的外部影響

外部宏觀環境因素在塑造Tapentadol市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解Tapentadol市場的競爭格局

對Tapentadol市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：他Tapentadol市場供應商的績效評估

FPNV 定位矩陣是評估Tapentadol市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製他Tapentadol市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，Tapentadol市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性肌肉骨骼疼痛的高發生率
      • 對非處方止痛藥的需求增加
      • 糖尿病流行和對止痛藥的需求不斷增加
    • 抑制因素
      • Tapentadol相關的副作用
    • 機會
      • 治療和治療開發的進展
      • 透過網路藥局獲得更多可得性
    • 任務
      • 嚴格的政府法規和替代品的可用性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章Tapentadol市場：按應用

  • 介紹
  • 咳嗽治療
  • 疼痛管理
    • 癌症痛
    • 神經病變疼痛

第7章Tapentadol市場：依最終用戶分類

  • 介紹
  • 診所
  • 醫院
  • 藥局

第8章 美洲Tapentadol市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區Tapentadol市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲Tapentadol市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Apotex Corporation
  • Arene Life Sciences limited
  • Cadila Pharmaceuticals Ltd.
  • Curia Global, Inc.
  • Grunenthal GmbH
  • IPCA Laboratories Ltd.
  • Johnson & Johnson Services, Inc.
  • Lupin Laboratories Ltd.
  • Manus Aktteva Biopharma LLP
  • Physicians Total Care, Inc.
  • Quality Care Products
  • Sun Pharmaceutical Industries Limited
  • Taj Pharmaceutical Limited
  • Tirupati Medicare Ltd
  • Virupaksha Group
Product Code: MRR-43676CF42C2A

The Tapentadol Market was valued at USD 3.86 billion in 2023, expected to reach USD 4.10 billion in 2024, and is projected to grow at a CAGR of 6.38%, to USD 5.95 billion by 2030.

Tapentadol, an analgesic used for pain management, particularly in managing moderate to severe acute pain, represents a vital segment within the pharmaceutical market. Its dual-action mechanism combines opioid receptor agonism and norepinephrine reuptake inhibition, enhancing pain control with potentially fewer side effects than traditional opioids. The necessity for alternative pain management solutions is increasingly pressing due to global concerns over opioid misuse, making tapentadol an attractive option for healthcare providers. It is primarily used in hospital settings, outpatient clinics, and by the palliative care sector. The end-use scope of tapentadol spans from acute post-operative pain management to chronic pain conditions like neuropathic and cancer pain. Influencing the market growth are factors such as the rising prevalence of chronic pain conditions, a growing elderly population, and increased demand for efficient and safer pain management options. Additionally, regulatory support for pain management therapies and ongoing clinical trials exploring other potential applications of tapentadol present substantial opportunities. Companies can capitalize on these by developing novel drug delivery systems or investigating combination therapies to improve efficacy and patient compliance. Nevertheless, the market faces limitations such as stringent regulatory requirements for pain medications, potential for dependency, and competition from both traditional opioids and new non-opioid analgesics. Moreover, ongoing debates about opioid use and stringent drug approval processes pose challenges. To overcome these barriers, focusing on innovation and research areas like improved drug formulations, abuse-deterrent properties, and personalized medicine approaches could be crucial. The market is competitive yet offers significant avenues for growth as companies that leverage technological advancements, such as digital health platforms and AI-driven pain management solutions, can attain a competitive edge. Understanding these dynamics is essential for companies striving to enhance their market position and offer sustainable pain management solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 3.86 billion
Estimated Year [2024] USD 4.10 billion
Forecast Year [2030] USD 5.95 billion
CAGR (%) 6.38%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tapentadol Market

The Tapentadol Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High occurrence of chronic musculoskeletal pain
    • Rising demand for over-the-counter painkillers
    • Escalating prevalence of diabetes and increasing need for analgesics
  • Market Restraints
    • Side effects associated with tapentadol
  • Market Opportunities
    • Advancement in treatment and therapeutics development
    • Exponential availability through online pharmacies
  • Market Challenges
    • Strict government regulations and availability of substitute

Porter's Five Forces: A Strategic Tool for Navigating the Tapentadol Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tapentadol Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tapentadol Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tapentadol Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tapentadol Market

A detailed market share analysis in the Tapentadol Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tapentadol Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tapentadol Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Tapentadol Market

A strategic analysis of the Tapentadol Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Tapentadol Market, highlighting leading vendors and their innovative profiles. These include Apotex Corporation, Arene Life Sciences limited, Cadila Pharmaceuticals Ltd., Curia Global, Inc., Grunenthal GmbH, IPCA Laboratories Ltd., Johnson & Johnson Services, Inc., Lupin Laboratories Ltd., Manus Aktteva Biopharma LLP, Physicians Total Care, Inc., Quality Care Products, Sun Pharmaceutical Industries Limited, Taj Pharmaceutical Limited, Tirupati Medicare Ltd, and Virupaksha Group.

Market Segmentation & Coverage

This research report categorizes the Tapentadol Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Application, market is studied across Cough Treatment and Pain Management. The Pain Management is further studied across Cancer Pain and Neuropathic Pain.
  • Based on End User, market is studied across Clinic, Hospital, and Pharmacy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High occurrence of chronic musculoskeletal pain
      • 5.1.1.2. Rising demand for over-the-counter painkillers
      • 5.1.1.3. Escalating prevalence of diabetes and increasing need for analgesics
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects associated with tapentadol
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement in treatment and therapeutics development
      • 5.1.3.2. Exponential availability through online pharmacies
    • 5.1.4. Challenges
      • 5.1.4.1. Strict government regulations and availability of substitute
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Tapentadol Market, by Application

  • 6.1. Introduction
  • 6.2. Cough Treatment
  • 6.3. Pain Management
    • 6.3.1. Cancer Pain
    • 6.3.2. Neuropathic Pain

7. Tapentadol Market, by End User

  • 7.1. Introduction
  • 7.2. Clinic
  • 7.3. Hospital
  • 7.4. Pharmacy

8. Americas Tapentadol Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Tapentadol Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Tapentadol Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Apotex Corporation
  • 2. Arene Life Sciences limited
  • 3. Cadila Pharmaceuticals Ltd.
  • 4. Curia Global, Inc.
  • 5. Grunenthal GmbH
  • 6. IPCA Laboratories Ltd.
  • 7. Johnson & Johnson Services, Inc.
  • 8. Lupin Laboratories Ltd.
  • 9. Manus Aktteva Biopharma LLP
  • 10. Physicians Total Care, Inc.
  • 11. Quality Care Products
  • 12. Sun Pharmaceutical Industries Limited
  • 13. Taj Pharmaceutical Limited
  • 14. Tirupati Medicare Ltd
  • 15. Virupaksha Group

LIST OF FIGURES

  • FIGURE 1. TAPENTADOL MARKET RESEARCH PROCESS
  • FIGURE 2. TAPENTADOL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TAPENTADOL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TAPENTADOL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TAPENTADOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TAPENTADOL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TAPENTADOL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TAPENTADOL MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TAPENTADOL MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS TAPENTADOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS TAPENTADOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES TAPENTADOL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES TAPENTADOL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. TAPENTADOL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. TAPENTADOL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TAPENTADOL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TAPENTADOL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TAPENTADOL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TAPENTADOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TAPENTADOL MARKET DYNAMICS
  • TABLE 7. GLOBAL TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TAPENTADOL MARKET SIZE, BY COUGH TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TAPENTADOL MARKET SIZE, BY CANCER PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TAPENTADOL MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TAPENTADOL MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TAPENTADOL MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TAPENTADOL MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS TAPENTADOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES TAPENTADOL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. TAPENTADOL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. TAPENTADOL MARKET, FPNV POSITIONING MATRIX, 2023